Literature DB >> 20813506

Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: one-year follow-up from the Eiffel study.

R Segarra1, N Ojeda, J Peña, J García, A Rodriguez-Morales, I Ruiz, R Hidalgo, J A Burón, J I I Eguiluz, M Gutiérrez.   

Abstract

OBJECTIVES: The Eiffel study is a longitudinal, naturalistic study of patients with first episode psychosis (FEP) designed to evaluate the predictive value of defective insight on treatment adherence and global functioning.
METHODS: Five hundred seventy-seven patients with FEP were assessed at baseline and at a 1-year follow-up. They were compared in terms of sociodemographic factors, psychopathology, insight, treatment adherence and functional outcome. Longitudinal functionality was prospectively assessed with the clinical global impression (CGI) and global assessment of functioning (GAF) rating scales.
RESULTS: At baseline, up to 50% of our sample presented with a lack of insight. Most clinical symptoms, including insight, improved over the follow-up period. Insight, education and social withdrawal significantly predicted CGI and GAF at follow-up. Insight and level of education were predictive of treatment adherence.
CONCLUSIONS: Insight significantly predicted the general clinical course, treatment adherence and functional outcome in our FEP sample after 1 year. Only education additionally accounted for the longitudinal course. Since our results suggest that better insight improves treatment adherence and consequently clinical course and functional outcome, insight could be a specific target of treatment in early intervention programs.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813506     DOI: 10.1016/j.eurpsy.2010.06.003

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  10 in total

1.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

3.  Predictors of help-seeking duration in adult-onset psychosis in Hong Kong.

Authors:  Christy L M Hui; Jennifer Y M Tang; Gloria H Y Wong; W C Chang; Sherry K W Chan; Edwin H M Lee; Eric Y H Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-04-26       Impact factor: 4.328

Review 4.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

5.  Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients.

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Fabio Rugani; Matteo Pacini; Francesco Lamanna; Silvia Bacciardi; Giulio Perugi; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Front Psychiatry       Date:  2012-07-09       Impact factor: 4.157

6.  Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.

Authors:  Franck Jean Baylé; Arnaud Tessier; Sophie Bouju; David Misdrahi
Journal:  Patient Prefer Adherence       Date:  2015-09-16       Impact factor: 2.711

7.  Medication adherence in first-episode psychosis and its association with psychopathology.

Authors:  Vijaya Raghavan; Greeshma Mohan; Subhashini Gopal; Mangala Ramamurthy; Thara Rangaswamy
Journal:  Indian J Psychiatry       Date:  2019       Impact factor: 1.759

8.  Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.

Authors:  Julien Elowe; Julie Ramain; Alessandra Solida; Philippe Conus; Philippe Golay
Journal:  Eur Psychiatry       Date:  2022-08-15       Impact factor: 7.156

9.  Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide, health insurance data-based study.

Authors:  Sung Woo Joo; Harin Kim; Young Tak Jo; Soojin Ahn; Young Jae Choi; Woohyeok Choi; Soyeon Park; Jungsun Lee
Journal:  BMC Psychiatry       Date:  2022-10-08       Impact factor: 4.144

10.  Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.

Authors:  Delphine Raucher-Chéné; Michael Bodnar; Katie M Lavigne; Ashok Malla; Ridha Joober; Martin Lepage
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.